Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Racial and workplace disparities in seroprevalence of SARS-CoV-2 in Baton Rouge, Louisiana, July 15-31, 2020

View ORCID ProfileAmy K. Feehan, View ORCID ProfileCruz Velasco, View ORCID ProfileDaniel Fort, View ORCID ProfileJeffrey H. Burton, View ORCID ProfileEboni Price-Haywood, View ORCID ProfilePeter T. Katzmarzyk, View ORCID ProfileJulia Garcia-Diaz, View ORCID ProfileLeonardo Seoane
doi: https://doi.org/10.1101/2020.08.26.20180968
Amy K. Feehan
1Ochsner Clinic Foundation, New Orleans, LA, USA (A. K. Feehan, C. Velasco, D. Fort, J. H. Burton, E. Price-Haywood, J. Garcia-Diaz, L. Seoane)
2The University of Queensland Faculty of Medicine, Ochsner Clinical School, New Orleans, LA, USA (A. K. Feehan, J. Garcia-Diaz, E. Price-Haywood, L. Seoane)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amy K. Feehan
  • For correspondence: amy.feehan{at}ochsner.org
Cruz Velasco
1Ochsner Clinic Foundation, New Orleans, LA, USA (A. K. Feehan, C. Velasco, D. Fort, J. H. Burton, E. Price-Haywood, J. Garcia-Diaz, L. Seoane)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cruz Velasco
Daniel Fort
1Ochsner Clinic Foundation, New Orleans, LA, USA (A. K. Feehan, C. Velasco, D. Fort, J. H. Burton, E. Price-Haywood, J. Garcia-Diaz, L. Seoane)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Fort
Jeffrey H. Burton
1Ochsner Clinic Foundation, New Orleans, LA, USA (A. K. Feehan, C. Velasco, D. Fort, J. H. Burton, E. Price-Haywood, J. Garcia-Diaz, L. Seoane)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey H. Burton
Eboni Price-Haywood
1Ochsner Clinic Foundation, New Orleans, LA, USA (A. K. Feehan, C. Velasco, D. Fort, J. H. Burton, E. Price-Haywood, J. Garcia-Diaz, L. Seoane)
2The University of Queensland Faculty of Medicine, Ochsner Clinical School, New Orleans, LA, USA (A. K. Feehan, J. Garcia-Diaz, E. Price-Haywood, L. Seoane)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eboni Price-Haywood
Peter T. Katzmarzyk
3Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA (P.T. Katzmarzyk)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter T. Katzmarzyk
Julia Garcia-Diaz
1Ochsner Clinic Foundation, New Orleans, LA, USA (A. K. Feehan, C. Velasco, D. Fort, J. H. Burton, E. Price-Haywood, J. Garcia-Diaz, L. Seoane)
2The University of Queensland Faculty of Medicine, Ochsner Clinical School, New Orleans, LA, USA (A. K. Feehan, J. Garcia-Diaz, E. Price-Haywood, L. Seoane)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia Garcia-Diaz
Leonardo Seoane
1Ochsner Clinic Foundation, New Orleans, LA, USA (A. K. Feehan, C. Velasco, D. Fort, J. H. Burton, E. Price-Haywood, J. Garcia-Diaz, L. Seoane)
2The University of Queensland Faculty of Medicine, Ochsner Clinical School, New Orleans, LA, USA (A. K. Feehan, J. Garcia-Diaz, E. Price-Haywood, L. Seoane)
4Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA (L. Seoane)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Leonardo Seoane
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Using paired molecular and antibody testing for SARS-CoV-2 infection, we determined point prevalence and seroprevalence in a municipality in Louisiana, USA during the second phase of reopening. Infections were highly variable by race, work environment, and ZIP code. Census-weighted seroprevalence and point prevalence were 3.6% and 3.0%, respectively.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was funded by the Baton Rouge Area Foundation, Louisiana COVID-19 Health Equity Task Force and The Humana Foundation, with additional support from The Blue Cross and Blue Shield of Louisiana Foundation, and Healthy Blue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ochsner Health IRB approved this study and can be contacted at irb{at}ochsner.org or by phone at 504-842-3535.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

De-identified data is available upon reasonable request to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 01, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Racial and workplace disparities in seroprevalence of SARS-CoV-2 in Baton Rouge, Louisiana, July 15-31, 2020
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Racial and workplace disparities in seroprevalence of SARS-CoV-2 in Baton Rouge, Louisiana, July 15-31, 2020
Amy K. Feehan, Cruz Velasco, Daniel Fort, Jeffrey H. Burton, Eboni Price-Haywood, Peter T. Katzmarzyk, Julia Garcia-Diaz, Leonardo Seoane
medRxiv 2020.08.26.20180968; doi: https://doi.org/10.1101/2020.08.26.20180968
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Racial and workplace disparities in seroprevalence of SARS-CoV-2 in Baton Rouge, Louisiana, July 15-31, 2020
Amy K. Feehan, Cruz Velasco, Daniel Fort, Jeffrey H. Burton, Eboni Price-Haywood, Peter T. Katzmarzyk, Julia Garcia-Diaz, Leonardo Seoane
medRxiv 2020.08.26.20180968; doi: https://doi.org/10.1101/2020.08.26.20180968

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (754)
  • Anesthesia (221)
  • Cardiovascular Medicine (3288)
  • Dentistry and Oral Medicine (364)
  • Dermatology (277)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
  • Epidemiology (13358)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5147)
  • Geriatric Medicine (481)
  • Health Economics (782)
  • Health Informatics (3264)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (429)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14622)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (127)
  • Nephrology (522)
  • Neurology (4919)
  • Nursing (262)
  • Nutrition (727)
  • Obstetrics and Gynecology (882)
  • Occupational and Environmental Health (795)
  • Oncology (2519)
  • Ophthalmology (723)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (556)
  • Psychiatry and Clinical Psychology (4205)
  • Public and Global Health (7499)
  • Radiology and Imaging (1704)
  • Rehabilitation Medicine and Physical Therapy (1011)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (205)